BUSINESS WIRE

FDA Approves MICARDIS® (Telmisartan) As the First Treatment in its Class to Reduce the Risk of Heart Attack, Stroke, or Death from Cardiovascular Causes...

Loading media player...
Prof. Gordon McInnes, UK (Video: Business Wire)

Embed